News Corp vs AbbVie

Side-by-side comparison of AI visibility scores, market position, and capabilities

AbbVie leads in AI visibility (90 vs 31)

News Corp

EmergingTechnology

General

New York media and information (NASDAQ: NWSA); FY2025 $8.5B revenue, EBITDA record $1.4B+ (+14%), Foxtel sold to DAZN $2.1B (Dec 2024), WSJ 5.2M+ digital subs competing with Bloomberg for premium journalism and professional info.

AI VisibilityBeta
Overall Score
D31
Category Rank
#522 of 1167
AI Consensus
52%
Trend
stable
Per Platform
ChatGPT
39
Perplexity
36
Gemini
23

About

News Corporation is a New York City, New York-based global media and information services company — publicly traded on NASDAQ (NASDAQ: NWSA/NWS) — operating The Wall Street Journal, Dow Jones, HarperCollins Publishers, the New York Post, The Times, The Sun, The Australian, REA Group digital real estate, and realtor.com through Chairman Lachlan Murdoch and CEO Robert Thomson, reporting FY2025 revenues of approximately $8.5 billion with net income from continuing operations improving 71% to $648 million and Total Segment EBITDA increasing 14% to a record $1.4 billion+. News Corp emerged in its current form on June 28, 2013, when Rupert Murdoch separated the print, publishing, and information assets from the entertainment assets that became 21st Century Fox (now Fox Corporation). The company operates through five primary segments: Digital Real Estate Services (REA Group — the dominant Australian property portal — and Move, which operates realtor.com in the US), Dow Jones (The Wall Street Journal, Barron's, MarketWatch, Factiva — $2.3 billion revenue in FY2024, up 14% YoY, with 5.2+ million digital-only subscriptions growing 16% YoY), Book Publishing (HarperCollins, one of the world's largest trade publishers), News Media (newspapers in the US, UK, and Australia), and Subscription Video Services (Foxtel sold to DAZN in December 2024 for $2.1 billion, completing the divestiture). In FY2024, News Corp reported $9.88 billion in revenue, with digital revenues accounting for approximately 36% of total.

Full profile

AbbVie

LeaderHealthcare

General

Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.

AI VisibilityBeta
Overall Score
A90
Category Rank
#9 of 1167
AI Consensus
60%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
99
Gemini
83

About

AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.

Full profile

AI Visibility Head-to-Head

31
Overall Score
90
#522
Category Rank
#9
52
AI Consensus
60
stable
Trend
stable
39
ChatGPT
99
36
Perplexity
99
23
Gemini
83
22
Claude
96
36
Grok
95

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.